Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 14,667 | 16,060 | 8,620 | 17,267 | 4,997 |
| Cost of Goods | 13,248 | 14,410 | 7,227 | 15,505 | 3,578 |
| Gross Profit | 1,419 | 1,650 | 1,394 | 1,763 | 1,419 |
| Operating Expenses | 548 | 752 | 543 | 957 | 1,063 |
| Operating Income | 1,120 | 1,309 | 1,078 | 1,311 | 935 |
| Other Income | -39 | -2 | -27 | 46 | 3 |
| Pre-tax Income | 1,081 | 1,306 | 1,050 | 1,356 | 938 |
| Income Tax | N/A | N/A | N/A | -31 | 4 |
| Net Income Continuous | 1,081 | 1,306 | 1,050 | 1,387 | 934 |
| Net Income | $1,081 | $1,306 | $1,050 | $1,387 | $934 |
| EPS Basic Total Ops | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| EPS Basic Continuous Ops | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 |
| EPS Diluted Total Ops | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 |
| EPS Diluted Continuous Ops | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 |
| EBITDA(a) | $1,123 | $5,152 | $6,104 | $7,832 | $1,544 |